4.6 Article

Benchmarking of Mutation Diagnostics in Clinical Lung Cancer Specimens

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemical Research Methods

Fast and accurate long-read alignment with Burrows-Wheeler transform

Heng Li et al.

BIOINFORMATICS (2010)

Article Medicine, General & Internal

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Keith T. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Biochemical Research Methods

Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissues

Sandrine Dufort et al.

ANALYTICAL BIOCHEMISTRY (2009)

Article Medicine, Research & Experimental

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions

Martin L. Sos et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Medicine, General & Internal

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.

Peter C. Fong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer.

Rafael Rosell et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.

Tony S. Mok et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Biotechnology & Applied Microbiology

The genome sequencer FLX™ system-longer reads, more applications, straight forward bioinformatics and more complete data sets

Marcus Droege et al.

JOURNAL OF BIOTECHNOLOGY (2008)

Article Pathology

K-ras mutation detection in colorectal cancer using the Pyrosequencing technique

Angela Poehlmann et al.

PATHOLOGY RESEARCH AND PRACTICE (2007)

Article Pathology

Sensitive Sequencing method for KRAS mutation detection by pyrosequencing

S Ogino et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2005)

Article Medicine, General & Internal

Erlotinib in lung cancer - Molecular and clinical predictors of outcome

MS Tsao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

W Pao et al.

PLOS MEDICINE (2005)

Article Multidisciplinary Sciences

EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib

W Pao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)